MAPK14 and neoplasm: p38 signaling allows these dormant tumor cells to resist chemotherapy by activation of pro-survival mechanisms driven by upregulation of the protein kinases PERK and BiP, which prevent the activation of Bax, a pro-apoptotic protein [88] (Fig. 4).